Explore comprehensive CDMO services offered by OmniaBio, supporting end-to-end Anlaytical Testing, Drug Development and Manufacturing. OmniaBio enables faster, compliant, and scalable pharma innovation tailored to your needs.
Country: Canada
Description: OmniaBio is a global contract development and manufacturing organization (CDMO) specializing in cell and gene therapies, spun out from the Centre for Commercialization of Regenerative Medicine (CCRM). It provides a range of services from early-stage pre-clinical work through to commercial-scale manufacturing. The company aims to accelerate the development of advanced therapies by providing a full suite of services, including process development, analytical testing, and robust manufacturing capabilities.
